ANGPTL4 Attenuates Ang II-Induced Atrial Fibrillation and Fibrosis in Mice via PPAR Pathway
Atrial fibrillation (AF) is the more significant portion of arrhythmia in clinical practice, with inflammation and fibrosis as its central pathological mechanisms. This study aimed to investigate angiopoietin-like 4 (ANGPTL4) effects on angiotensin II- (Ang II-) induced AF and its related pathophysi...
Saved in:
Main Authors: | Xi Zhu, Xiaogang Zhang, Xinpeng Cong, Luoning Zhu, Zhongping Ning |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2021/9935310 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPAR-α regulates metabolic remodelling and
participates in myocardial fibrosis in patients with
atrial fibrillation of rheumatic heart disease
by: Xiaoying Hu, et al.
Published: (2024-07-01) -
Association of Autoantibodies against M2-Muscarinic Acetylcholine Receptor with Atrial Fibrosis in Atrial Fibrillation Patients
by: Guiling Ma, et al.
Published: (2019-01-01) -
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway
by: Laura La Paglia, et al.
Published: (2017-01-01) -
TRPV1 Activation Attenuates High-Salt Diet-Induced Cardiac Hypertrophy and Fibrosis through PPAR-δ Upregulation
by: Feng Gao, et al.
Published: (2014-01-01) -
Change in Atrial Fibrillation Burden over Time in Patients with Nonpermanent Atrial Fibrillation
by: Philipp Krisai, et al.
Published: (2020-01-01)